Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Not all progestins are the same: implications for usage.

Janet P Hapgood1, Dominique Koubovec, Ann Louw

  • 1Department of Biochemistry, University of Stellenbosch, Private Bag X1, Matieland 7602, South Africa. JHap@sun.ac.za

Trends in Pharmacological Sciences
|October 20, 2004
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Sex steroids, SHBG and type 2 diabetes in women: what do we really know?

Diabetologia·2026
Same author

Injectable contraceptives differentially affect the hypothalamic-pituitary-gonadal axis and amenorrhea incidence†.

Biology of reproduction·2026
Same author

Serum norethisterone (NET) levels in NET-enanthate (NET-EN) injectable contraception users substantially interfere with testosterone immunoassay measurements and confound interpretation of biological outcomes.

Contraception and reproductive medicine·2025
Same author

Injectable Contraceptives Differentially Affect Select CD4+ HIV-1 Target Cells in the Genital Tract but Not Systemically: Implications for HIV-1 Acquisition.

American journal of reproductive immunology (New York, N.Y. : 1989)·2025
Same author

Steroid receptors in hormone dependent or sensitive cancers: The field of play now and looking forward.

The Journal of steroid biochemistry and molecular biology·2024
Same author

The injectable contraceptives depot medroxyprogesterone acetate and norethisterone enanthate substantially and differentially decrease testosterone and sex hormone binding globulin levels: A secondary study from the WHICH randomized clinical trial.

PloS one·2024
Same journal

Engineering cells for solid tumor therapy.

Trends in pharmacological sciences·2026
Same journal

Targeting developmental reprogramming: hPSC insights for cancer interception.

Trends in pharmacological sciences·2026
Same journal

July 2026 issue first authors.

Trends in pharmacological sciences·2026
Same journal

Chronobiomaterials for circadian-aligned brain therapeutics.

Trends in pharmacological sciences·2026
Same journal

Biosensors for translatable GPCR bias.

Trends in pharmacological sciences·2026
Same journal

ECM stiffness and epigenetics in organ fibrosis.

Trends in pharmacological sciences·2026
See all related articles

Choosing the right synthetic progestin is crucial due to unexpected side-effects. Understanding the molecular mechanisms of medroxyprogesterone acetate and norethisterone can lead to safer hormone therapies and contraception.

Area of Science:

  • Pharmacology and Endocrinology
  • Reproductive Health
  • Drug Development

Background:

  • Recent clinical data reveal adverse effects associated with commonly used synthetic progestins in hormone replacement therapy and contraception.
  • The selection of synthetic progestins is critical for patient safety and therapeutic efficacy.
  • Existing progestins, such as medroxyprogesterone acetate and norethisterone, exhibit broad molecular actions.

Purpose of the Study:

  • To review the molecular mechanisms of action for widely used synthetic progestins, medroxyprogesterone acetate and norethisterone.
  • To contextualize these mechanisms within recent clinical findings on unexpected side-effects.
  • To explore future therapeutic strategies for developing more specific progestins.

Main Methods:

Related Experiment Videos

  • Literature review of clinical evidence on progestin side-effects.
  • Analysis of molecular mechanisms of action for medroxyprogesterone acetate and norethisterone.
  • Discussion of future research directions for targeted progestin development.

    • Main Results:

    • Medroxyprogesterone acetate and norethisterone, though widely used, possess relatively nonspecific molecular mechanisms.
    • These mechanisms may explain some of the observed unexpected clinical side-effects.
    • A need exists for progestins with enhanced specificity.

    Conclusions:

    • The choice of synthetic progestin significantly impacts patient outcomes due to varying side-effect profiles.
    • A deeper understanding of molecular mechanisms is essential for mitigating adverse events.
    • Future drug development should prioritize mechanism-based approaches for greater specificity and improved safety in progestin therapeutics.